Literature DB >> 15533908

Poly (AT) polymorphism in intron 11 of the XPC DNA repair gene enhances the risk of lung cancer.

M Soledad Marín1, M Felicitas López-Cima, Laura García-Castro, Teresa Pascual, Manuel G Marrón, Adonina Tardón.   

Abstract

Reduced DNA repair capacity due to inherited polymorphisms may increase the susceptibility to smoking-related cancers. In this report, we investigate the relationship between xeroderma pigmentosum complementary group C poly (AT) insertion/deletion polymorphism (XPC-PAT) of the XPC gene and lung cancer risk in a hospital-based case-control study of 359 newly diagnosed lung cancer patients and 375 control subjects matched on age, sex, and catchment area. The XPC genotype was determined by PCR-RFLP, and the results were analyzed using logistic regression, adjusting for relevant covariates. We found that the frequency of the PAT+/+ genotype was higher in the cases (20.6%) than in the controls (14.1%; P = 0.057) and that the PAT+/+ subjects were at significantly increased risk for lung cancer [adjusted odds ratio (OR), 1.60; 95% confidence interval (95% CI), 1.01-2.55]. Stratified analysis revealed that the risk was higher in former smokers (OR, 2.15; 95% CI, 1.07-4.31) and older people (OR, 2.76; 95% CI, 1.02-7.51), although this probably occurs due to 63.4% of cases older than 73 years being ex-smokers. When stratified by histologic type, the variant genotype was associated with statistically significant increased risk for squamous cell carcinoma (OR, 1.93; 95% CI, 1.06-3.51). In conclusion, our findings support the hypothesis that PAT and intron 11 C/A XPC polymorphisms are linked in the Spanish population and may contribute to the risk of developing lung cancer probably due to a higher frequency of deletion of exon 12 and reduced DNA repair capacity of the XPC protein.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15533908

Source DB:  PubMed          Journal:  Cancer Epidemiol Biomarkers Prev        ISSN: 1055-9965            Impact factor:   4.254


  29 in total

1.  Investigation of Leukocyte Telomere Length and Genetic Variants in Chromosome 5p15.33 as Prognostic Markers in Lung Cancer.

Authors:  Linda Kachuri; Jens Helby; Stig Egil Bojesen; David C Christiani; Li Su; Xifeng Wu; Adonina Tardón; Guillermo Fernández-Tardón; John K Field; Michael P Davies; Chu Chen; Gary E Goodman; Frances A Shepherd; Natasha B Leighl; Ming S Tsao; Yonathan Brhane; M Catherine Brown; Kevin Boyd; Daniel Shepshelovich; Lei Sun; Christopher I Amos; Geoffrey Liu; Rayjean J Hung
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2019-07       Impact factor: 4.254

2.  A meta-analysis of evidences on XPC polymorphisms and lung cancer susceptibility.

Authors:  Chuan Liu; Qinghua Yin; Jianbing Hu; Lian Li; Yingyi Zhang; Yajie Wang
Journal:  Tumour Biol       Date:  2013-02-06

3.  Note of clarification of data in the meta-analysis of evidences on XPC polymorphisms and lung cancer susceptibility.

Authors:  Qiang Zhang; Ganzhong Wei; Xiaoming Wu; Ying Luo
Journal:  Tumour Biol       Date:  2014-07-02

4.  Association of p21 Ser31Arg and p53 Arg72Pro polymorphisms with lung cancer risk in CAPUA study.

Authors:  Ana Souto-García; Ana Fernández-Somoano; Teresa Pascual; Sara M Álvarez-Avellón; Adonina Tardón
Journal:  Lung Cancer (Auckl)       Date:  2012-11-21

5.  Deletion of XPC leads to lung tumors in mice and is associated with early events in human lung carcinogenesis.

Authors:  M Christine Hollander; Robyn T Philburn; Andrew D Patterson; Susana Velasco-Miguel; Errol C Friedberg; R Ilona Linnoila; Albert J Fornace
Journal:  Proc Natl Acad Sci U S A       Date:  2005-09-02       Impact factor: 11.205

Review 6.  Association of XPC gene polymorphisms with susceptibility to prostate cancer: evidence from 3,936 subjects.

Authors:  Yan-Feng Zou; Jin-Hui Tao; Qian-Ling Ye; Hai-Feng Pan; Fa-Ming Pan; Hong Su; Dong-Qing Ye
Journal:  Genet Test Mol Biomarkers       Date:  2013-10-05

7.  Genetic polymorphisms in DNA repair genes as modulators of Hodgkin disease risk.

Authors:  Randa El-Zein; Claudia M Monroy; Carol J Etzel; Andrea C Cortes; Yun Xing; Amanda L Collier; Sara S Strom
Journal:  Cancer       Date:  2009-04-15       Impact factor: 6.860

8.  XPC intron11 C/A polymorphism as a risk factor for prostate cancer.

Authors:  Yoshihiro Yoshino; Shouhei Takeuchi; Takahiko Katoh; Yoshiki Kuroda
Journal:  Environ Health Prev Med       Date:  2016-01-08       Impact factor: 3.674

9.  Polymorphisms in XPC provide prognostic information in acute myeloid leukemia.

Authors:  Peipei Xu; Baoan Chen; Jifeng Feng; Lu Cheng; Guohua Xia; Yufeng Li; Jun Qian; Jiahua Ding; Zuhong Lu
Journal:  Int J Hematol       Date:  2012-09-12       Impact factor: 2.490

Review 10.  Genetic susceptibility to lung cancer--light at the end of the tunnel?

Authors:  Ariela L Marshall; David C Christiani
Journal:  Carcinogenesis       Date:  2013-01-24       Impact factor: 4.944

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.